dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2019-10-06T16:02:44Z
dc.date.accessioned2022-12-19T18:40:58Z
dc.date.available2019-10-06T16:02:44Z
dc.date.available2022-12-19T18:40:58Z
dc.date.created2019-10-06T16:02:44Z
dc.date.issued2018-01-01
dc.identifierJournal of Craniofacial Surgery, v. 29, n. 6, p. e617-e618, 2018.
dc.identifier1536-3732
dc.identifier1049-2275
dc.identifierhttp://hdl.handle.net/11449/188271
dc.identifier10.1097/SCS.0000000000004679
dc.identifier2-s2.0-85055613285
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5369309
dc.description.abstractNecrotizing fasciitis (NF) is a devastating disease that typically affects immunocompromised patients, chronically debilitated patients or drug users, but can also affect healthy patients. Necrotizing fasciitis can rapidly produce septic shock and requires immediate surgical management of the necrotic tissue. It is a bacterial infection that progresses rapidly and has a high mortality generally caused by aerobic and anaerobic bacteria. The patient was immunocompromised and drug user. During treatment, a combination of broad-spectrum antibiotic therapy with Ciprofloxacin and Metronidazole, besides the use of activated charcoal dressing composed of carbonized fabric and impregnated with 0.15% silver nitrate enveloped by layer of fabric without activated carbon, chemical–mechanical debridement with hydrogen peroxide, 0.9% saline, and povidone iodine. According to the patient presented, for the treatment of NF there is a need for broad-spectrum antibiotic therapy associated with surgical debridement, use of activated charcoal for antiseptic compression and general intensive care.
dc.languageeng
dc.relationJournal of Craniofacial Surgery
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectFace
dc.subjectInfection
dc.subjectNecrotizing fasciitis
dc.titleCervicofacial necrotizing fasciitis and drugs
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución